GeneDx: Empowering Individualized Healthcare

Published

Katherine Stueland, CEO of GeneDx, sits down with Nasdaq's Kristina Ayanian to discuss their mission to deliver health insights that inform diagnosis, direct treatment, and improve drug discovery.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now